Anastrozole 1mg/tab 50 Tabletten by Hilma Biocare

Usage

1. Obtain a pre-PCT blood panel measuring serum estradiol, LH, FSH, and total testosterone to establish your hormonal baseline and determine the correct starting dose of anastrozole.
2. Begin anastrozole at 0.5 mg to 1 mg daily once circulating androgens from your moderate cycle have cleared to a level at which natural testosterone production should resume — typically 14 days after the final long-ester injection.
3. Take each 1 mg tablet orally with water; the tablet may be split with a clean blade for 0.5 mg dosing if your pre-PCT estradiol is only moderately elevated and aggressive suppression is not indicated.
4. Introduce your SERM (tamoxifen or clomiphene) after the initial anastrozole phase has stabilized estradiol, following a sequential rather than simultaneous schedule to preserve anastrozole's plasma exposure.
5. Run anastrozole for the full prescribed phase — generally 4–6 weeks for a moderate cycle — then taper the dose rather than stopping abruptly to avoid estrogen rebound as aromatase inhibition lifts.
6. Complete exit bloodwork at the end of PCT to confirm that LH, FSH, total testosterone, and estradiol are within the expected recovery range before discontinuing all post-cycle compounds.

Warnings

Frequently asked questions

What does a standard PCT protocol look like after a moderate androgenic cycle?

A standard post-cycle protocol following a moderate cycle typically runs 4–6 weeks and combines an aromatase inhibitor such as anastrozole with a SERM. Anastrozole is generally introduced first — at 0.5–1 mg daily — to control aromatase activity during the androgen washout phase, then tapered as the SERM (tamoxifen or clomiphene) assumes the primary role of stimulating LH and FSH release.

What anastrozole dose is appropriate for PCT after moderate testosterone or nandrolone use?

For moderate-cycle PCT, a starting dose of 0.5 mg to 1 mg anastrozole daily is widely used, adjusted based on pre-PCT estradiol bloodwork. Users with naturally higher aromatase activity or those who experienced significant estrogen-related symptoms on-cycle often require the full 1 mg daily dose rather than the lower split schedule used in lighter recovery contexts.

How long does hormonal recovery typically take after a moderate steroid cycle?

After a moderate cycle, LH, FSH, and endogenous testosterone levels typically take 6–10 weeks to return to pre-cycle baseline, compared to the 4–5 weeks often sufficient after a mild protocol. The longer suppression period and greater axis inhibition from moderate cycles mean anastrozole may need to be maintained for 3–4 weeks rather than being phased out after 2 weeks.

Can Hilma Biocare Anastrozole tablets be split for lower-dose administration during PCT?

Yes — Hilma Biocare's 1 mg tablet format is suitable for splitting to achieve a 0.5 mg dose, which is a common starting point when PCT bloodwork shows estradiol within a moderately elevated but not severely high range. Each tablet is compressed under GMP-certified conditions with content-uniformity testing, meaning the active ingredient is evenly distributed and splitting delivers a reliable half-dose rather than an inconsistent fraction.

How many tablets does the 50-tablet pack provide for a full moderate-cycle PCT course?

At 1 mg daily, the 50-tablet pack covers a full 7-week supply — sufficient for most standard moderate-cycle PCT phases of 4–6 weeks, with a buffer for taper adjustments. At 0.5 mg daily, the same pack extends to 14 weeks, making it suitable for conservative or extended recovery protocols where lower ongoing estrogen suppression is preferred. (2) angle_used

Manufacturer

Hilma Biocare's approach to finished-product release for its oral tablet range is structured around compound-specific analytical documentation rather than a shared portfolio certificate: the Anastrozole 1mg/tab formulation carries its own product-level dossier in which API identity verification, HPLC-determined potency at both the raw-material intake stage and the finished-tablet release stage, and in-process tablet-weight data recorded during GMP-certified compression are maintained as a discrete batch record. This architecture means that the release decision for each production run of Anastrozole 1mg/tab is supported by data generated exclusively for that SKU — not inferred from adjacent items in the Hilma Biocare oral catalogue. LAL (Limulus Amebocyte Lysate) endotoxin testing is applied to the incoming anastrozole API as a contamination baseline measure before any tablet compression begins, providing a pre-compression quality gate that carries forward into the finished product's traceability record. GMP certification governs the compression environment, with temperature, humidity, and particulate monitoring maintained throughout the production run.